A recent study demonstrated the safety of cilostazol in patients with mild cognitive impairment (MCI), but did not demonstrate any efficacy in preventing disease progression. However, after administration of cilostazol, the ...
Dec 6, 2023
0
0
Twice daily non-invasive electrical stimulation of the brain may boost mental processes (cognitive function) in people with Alzheimer's disease, suggest the results of a small clinical trial published online in the open access ...
Dec 5, 2023
0
8
A study suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure. This finding, ...
Dec 4, 2023
0
32
It's getting towards the time of the year when you might feel more overwhelmed than usual. There are work projects to finish and perhaps exams in the family. Not to mention the pressures of organizing holidays or gifts. Burnout ...
Dec 1, 2023
0
5
We know sedentary behavior is bad for our health, especially for those of us who sit at a desk all day or in front of the TV each night. It has even been linked to mild cognitive impairment. Previous research has suggested ...
Nov 29, 2023
0
17
Black patients underwent medical imaging for cognitive impairment years later than white and Hispanic patients and were less frequently tested with MRI, according to research being presented at the annual meeting of the Radiological ...
Nov 27, 2023
0
0
Two stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed.
Nov 20, 2023
0
0
Old people who follow a Mediterranean diet are at a lower risk of cognitive decline, according to a study published in the journal Molecular Nutrition and Food Research. The study provides new evidence for a better understanding ...
Nov 17, 2023
0
94
Scientists at The University of Texas at Dallas Center for Vital Longevity (CVL) have published new evidence that shows changes in brain network patterns that occur in early-stage Alzheimer's disease differ from those associated ...
Nov 16, 2023
0
32
The use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to a study published in the Nov. 16 issue ...
Nov 16, 2023
0
0
